[Experiences with a new percutaneous anti-rheumatism drug].
D002986:Clinical Trials as Topic; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use*
D009539:Nicotinic Acids; D010276:Parasympatholytics; D012459:Salicylates
Erfahrungen mit einem neuen perkutanen Antirheumatikum.